Page last updated: 2024-10-27

flurbiprofen and Stevens-Johnson Syndrome

flurbiprofen has been researched along with Stevens-Johnson Syndrome in 1 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roujeau, JC1
Albengres, E1
Moritz, S1
Piacentino, A1
Cuny, M1
Revuz, J1
Touraine, R1

Other Studies

1 other study available for flurbiprofen and Stevens-Johnson Syndrome

ArticleYear
Lymphocyte transformation test in drug-induced toxic epidermal necrolysis.
    International archives of allergy and applied immunology, 1985, Volume: 78, Issue:1

    Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Dipyrone; Drug Combinations; Female; Flurbiprofen; Hu

1985